Latest News

  • Alkermes Reschedules Third Quarter 2020 Financial Results Conference Call to 10:30 a.m. ET Read More
  • Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations Read More
  • Alkermes to Host Conference Call to Discuss Third Quarter 2020 Financial Results Read More
  • FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder Read More

Investors

Response to Current Events